Published in
Elsevier, Journal of Geriatric Oncology, 2(10), p. 304-310, 2019
DOI: 10.1016/j.jgo.2018.11.011
Links
Tools
Cetuximab monotherapy and cetuximab plus capecitabine as first-line treatment in older patients with RAS- and BRAF wild-type metastatic colorectal cancer. Results of the multicenter phase II trial SAKK 41/10
Journal article published in 2019 by
Dirk L. Kienle,
Daniel Dietrich,
Karin Ribi 
,
Andreas Wicki ,
Luca Quagliata,
Ralph C. Winterhalder,
Dieter Koeberle,
Daniel Horber,
Sara Bastian,
Marc Kueng,
Piercarlo Saletti,
Daniel Helbling ,
Daniela Baertschi,
Alessandro Lugli,
Juerg Bernhard
and other authors.
,
Andreas Wicki ,
Luca Quagliata,
Ralph C. Winterhalder,
Dieter Koeberle,
Daniel Horber,
Sara Bastian,
Marc Kueng,
Piercarlo Saletti,
Daniel Helbling ,
Daniela Baertschi,
Alessandro Lugli,
Juerg Bernhard
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 